We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report World - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

World - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Global Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size

The global medicaments containing insulin market dropped modestly to $X in 2021, waning by -3.5% against the previous year. Overall, consumption, however, recorded a deep setback. Over the period under review, the global market attained the peak level at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production

In value terms, medicaments containing insulin production rose markedly to $X in 2021 estimated in export price. Overall, production, however, recorded a pronounced decline. The growth pace was the most rapid in 2016 when the production volume increased by 8.8% against the previous year. Over the period under review, global production hit record highs at $X in 2012; however, from 2013 to 2021, production remained at a lower figure.

Medicaments Containing Insulin Exports

Exports

In 2021, shipments abroad of medicaments containing insulin but not antibiotics decreased by -39.7% to X tons for the first time since 2017, thus ending a three-year rising trend. In general, exports, however, continue to indicate a resilient increase. The growth pace was the most rapid in 2019 with an increase of 84% against the previous year. Over the period under review, the global exports hit record highs at X tons in 2020, and then fell markedly in the following year.

In value terms, medicaments containing insulin exports dropped sharply to $X in 2021. Overall, exports showed a abrupt slump. The pace of growth was the most pronounced in 2016 when exports increased by 31% against the previous year. The global exports peaked at $X in 2012; however, from 2013 to 2021, the exports failed to regain momentum.

Exports by Country

The United States prevails in exports structure, recording X tons, which was near 92% of total exports in 2021. Thailand (X tons) held a minor share of total exports.

Exports from the United States increased at an average annual rate of +13.1% from 2012 to 2021. At the same time, Thailand (+102.4%) displayed positive paces of growth. Moreover, Thailand emerged as the fastest-growing exporter exported in the world, with a CAGR of +102.4% from 2012-2021. The United States (+39 p.p.) and Thailand (+2.7 p.p.) significantly strengthened its position in terms of the global exports, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the United States ($X) remains the largest medicaments containing insulin supplier worldwide, comprising 84% of global exports. The second position in the ranking was taken by Thailand ($X), with a 0.6% share of global exports.

From 2012 to 2021, the average annual rate of growth in terms of value in the United States totaled -6.6%.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, rising by 4.4% against the previous year. Overall, the export price, however, faced a abrupt contraction. The pace of growth was the most pronounced in 2016 an increase of 40%. Over the period under review, the average export prices hit record highs at $X per ton in 2012; however, from 2013 to 2021, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2021, amid the top suppliers, the country with the highest price was the United States ($X per ton), while Thailand stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the United States (-17.4%).

Medicaments Containing Insulin Imports

Imports

In 2021, approx. X tons of medicaments containing insulin but not antibiotics were imported worldwide; which is down by -51.8% against the previous year. Over the period under review, imports faced a abrupt slump. The most prominent rate of growth was recorded in 2020 with an increase of 202% against the previous year. Global imports peaked at X tons in 2012; however, from 2013 to 2021, imports failed to regain momentum.

In value terms, medicaments containing insulin imports contracted sharply to $X in 2021. Overall, imports continue to indicate a abrupt descent. The most prominent rate of growth was recorded in 2016 when imports increased by 87% against the previous year. Over the period under review, global imports attained the maximum at $X in 2012; however, from 2013 to 2021, imports stood at a somewhat lower figure.

Imports by Country

Denmark dominates imports structure, finishing at X tons, which was near 67% of total imports in 2021. Brazil (X tons) took a 6.8% share (based on physical terms) of total imports, which put it in second place, followed by Malaysia (4.8%). The following importers - Nigeria (X tons), Kuwait (X tons), Ethiopia (X tons) and Japan (X tons) - together made up 9.6% of total imports.

Imports into Denmark increased at an average annual rate of +27.5% from 2012 to 2021. At the same time, Brazil (+42.6%), Japan (+32.4%), Ethiopia (+17.3%), Kuwait (+8.8%) and Malaysia (+2.0%) displayed positive paces of growth. Moreover, Brazil emerged as the fastest-growing importer imported in the world, with a CAGR of +42.6% from 2012-2021. By contrast, Nigeria (-2.5%) illustrated a downward trend over the same period. While the share of Denmark (+67 p.p.), Brazil (+6.7 p.p.), Malaysia (+3.8 p.p.), Kuwait (+2.5 p.p.), Nigeria (+2 p.p.), Ethiopia (+2 p.p.) and Japan (+1.6 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Denmark ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics worldwide, comprising 66% of global imports. The second position in the ranking was taken by Brazil ($X), with a 6.3% share of global imports. It was followed by Nigeria, with a 4.4% share.

From 2012 to 2021, the average annual rate of growth in terms of value in Denmark totaled +20.7%. In the other countries, the average annual rates were as follows: Brazil (+37.4% per year) and Nigeria (+10.8% per year).

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, with an increase of 73% against the previous year. In general, the import price recorded a noticeable increase. The pace of growth was the most pronounced in 2016 an increase of 103%. Global import price peaked at $X per ton in 2018; however, from 2019 to 2021, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2021, amid the top importers, the country with the highest price was Japan ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Japan (+22.1%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

Denmark remains the largest medicaments containing insulin consuming country worldwide, comprising approx. 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. The third position in this ranking was occupied by Pakistan, with a 3.6% share.
The country with the largest volume of medicaments containing insulin production was the U.S., comprising approx. 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. The third position in this ranking was occupied by Pakistan, with a 2.5% share.
In value terms, the U.S. remains the largest medicaments containing insulin supplier worldwide, comprising 93% of global exports. The second position in the ranking was occupied by Thailand, with a 0.5% share of global exports.
In value terms, Denmark constitutes the largest market for imported medicaments containing insulin but not antibiotics worldwide, comprising 44% of global imports. The second position in the ranking was occupied by Iran, with a 16% share of global imports. It was followed by China, with a 15% share.
In 2020, the average medicaments containing insulin export price amounted to $42,078 per ton, with a decrease of -25.4% against the previous year.
The average medicaments containing insulin import price stood at $75,570 per ton in 2020, declining by -61% against the previous year.

This report provides an in-depth analysis of the global medicaments containing insulin market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:

+ the largest producing countries

Data coverage:

  • Global market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Global production, split by region and country
  • Global trade (exports and imports)
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. GLOBAL PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY

  8. 8. GLOBAL IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. GLOBAL EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • United States
    • China
    • Japan
    • Germany
    • United Kingdom
    • France
    • Brazil
    • Italy
    • Russian Federation
    • India
    • Canada
    • Australia
    • Republic of Korea
    • Spain
    • Mexico
    • Indonesia
    • Netherlands
    • Turkey
    • Saudi Arabia
    • Switzerland
    • Sweden
    • Nigeria
    • Poland
    • Belgium
    • Argentina
    • Norway
    • Austria
    • Thailand
    • United Arab Emirates
    • Colombia
    • Denmark
    • South Africa
    • Malaysia
    • Israel
    • Singapore
    • Egypt
    • Philippines
    • Finland
    • Chile
    • Ireland
    • Pakistan
    • Greece
    • Portugal
    • Kazakhstan
    • Algeria
    • Czech Republic
    • Qatar
    • Peru
    • Romania
    • Vietnam

  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Asia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 353

This report provides an in-depth analysis of the medicaments containing insulin market in Asia.

EU - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 237

This report provides an in-depth analysis of the medicaments containing insulin market in the EU.

U.S. - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 297

This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..

China - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 248

This report provides an in-depth analysis of the medicaments containing insulin market in China.

Free Data: Medicaments Containing Insulin But Not Antibiotics - World
Table
Medicaments Containing Insulin But Not Antibiotics - World - Table
Dashboard
Medicaments Containing Insulin But Not Antibiotics - World - Dashboard
Report
Medicaments Containing Insulin But Not Antibiotics - World - Report